SP 500 Edges Higher as Healthcare and Tech Rally Communication Services Weighs Greenlanders Protest New US Consulate as Trumps Greenland Ambitions Spark Tensions Private Sector Hiring Exceeds Expectations in April ADP Data Shows Consumer Sentiment Plunges to Record Low in May as Gas Prices Surge Amid Iran Conflict Truist Raises Flywire Price Target on Q1 Revenue Beat and Guidance Upgrade AXT Inc Shares Surge to Record High as Investor Meeting Approaches Crocs Inc CROX Q1 2026 Earnings Strong EPS Beat Amidst Mixed Expectations IONS Q1 2026 Earnings Narrower Loss Beats Estimates by 397 YORW Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Higher VSAT Q1 2026 Earnings Stellar EPS Beat Drives Positive Market Reaction DDL Q4 2025 Earnings Profitability Highlight as EPS Reported at 041 Ambow Education AMBO Q1 2012 Earnings EPS of 26700 Misses 8843 Estimate by 40194 Stock Rises 569 Chipotle Mexican Grill CMG Slightly Higher as Traders Watch Key Support and Resistance Levels Flexsteel Industries FLXS Holds Steady Near Support as Trading Range Narrows Oculis Holding AG Warrants OCSAW Hold Steady at 1966 Key Levels in Focus Via Renewables Preferred Stock VIASP Holds Steady Near Support Level 60 Degrees Pharmaceuticals SXTP Dips 134 as Shares Test Support Level Why Chasing High Returns Can Backfire The Case for a Disciplined Investment Approach GGAL Q1 2026 Earnings EPS Misses Estimates as Argentine Bank Faces Headwinds Infleqtion Inc INFQ Pressured Stock Declines 135 as Support Levels Come into Focus RB Global Inc Q1 2026 Earnings EPS Slightly Beats Estimates Shares Edge Higher NWE Q1 2026 Earnings EPS Beats Estimates by 69 Amid Solid Operational Performance Seaport Entertainment Group SEG Q1 2026 Earnings EPS Misses Estimates Amid Operational Transition Versus Systems Inc Q4 2025 Earnings Continued Losses Amid Restructuring Efforts Axsome Therapeutics Q1 2026 Earnings WiderThanExpected Loss Weighs on Sentiment ROIV Q1 2026 Earnings WiderThanExpected Loss Highlights PreRevenue Pipeline Costs Genprex GNPX Q1 2026 Earnings Continued RD Investment as Gene Therapy Pipeline Progresses